Zacks Equity Research Highlights Key Developments in Stocks
In a recent update, Zacks Equity Research highlights significant news and events impacting top stocks in the market. The announcement covers five prominent companies: Huntington Bancshares, Franklin Credit Management Corp., Intel Corp., Huaneng Power International, and Haemonetics Corp. Analysts at Zacks Equity Research have discussed these companies' recent developments, including restructuring agreements, revenue growth, and financial results.
Key Takeaways:
- Huntington Bancshares, Inc. (NASDAQ: HBAN) restructured its credit relationship with Franklin Credit Management Corp. (OTC: FCMC), eliminating $615 million in problem loans and resulting in a one-time $160 million after-tax benefit.
- Intel Corp. (NASDAQ: INTC) generated increased revenue from the notebook market, driven by consumer demand, with corporate customers transitioning to mobile platforms.
- Huaneng Power International (NYSE: HNP) reported operating revenue of RMB67.564 billion, a 35.76% increase over 2007 revenue, for the year ended December 31, 2008.
- Haemonetics Corp. (NYSE: HAE) saw continued strong performance in the blood collection and processing market, with sales growth reaching 15.5% and net margin remaining in the 10% range.
- Analysts at Zacks Equity Research upgraded Haemonetics Corp. to a BUY recommendation due to the company's strong financial performance and prospects.
Statistics:
- $615 million in problem loans eliminated by Huntington Bancshares, Inc. through its restructuring with Franklin Credit Management Corp.
- 35.76% increase in operating revenue for Huaneng Power International from 2007 to 2008.
- 15.5% sales growth for Haemonetics Corp. in the blood collection and processing market.
Sources:
- Zacks.com - Analyst Blog featuring Huntington Bancshares, Inc. (NASDAQ: HBAN), Franklin Credit Management Corp. (OTC: FCMC), Intel Corp. (NASDAQ: INTC), Huaneng Power International (NYSE: HNP), and Haemonetics Corp. (NYSE: HAE)
- Zacks Equity Research - Profit from the Pros newsletter (http://at.zacks.com/?id=4579)
- Zacks Investment Research, Inc. - http://www.zacks.com/about/zacks-history
- Disclaimer and Performance Numbers - http://www.zacks.com/performance